FDA recommends sponsors plan to include race, ethnicity in clinical trial design

Regulatory NewsRegulatory NewsBiologicsClinical TrialsCombination ProductsComplianceDiagnosticsEthicsMedical DevicesNorth AmericaPharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and Development